Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerosis

Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

69 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerosis trial results

Completed

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

NCT03257358

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Cullman, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Berkeley, California, United States
View all 66 locations
View Trial Details
Completed

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

NCT02792218

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Berkeley, California, United States
  • Novartis Investigative Site Fullerton, California, United States
  • Novartis Investigative Site Sacramento, California, United States
View all 166 locations
View Trial Details
Completed

Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients

NCT01628393

Conditions
Relapsing Multiple Sclerosis
Locations
  • Alta Bates Summit Medical Center Berkeley, California, United States
  • Neuro Pain Medical Center Fresno, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • The Neurological Institute PA Charlotte, North Carolina, United States
View all 58 locations
View Trial Details
Completed

Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)

NCT01939002

Conditions
Relapsing Multiple Sclerosis
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
View all 38 locations
View Trial Details
Completed

Long-Term Safety and Efficacy Study of Peginterferon Beta-1a

NCT01332019

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Lexington, Kentucky, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Raleigh, North Carolina, United States
View all 151 locations
View Trial Details

Related conditions